Revance Therapeutic (RVNC) PT Lowered to $3 at Barclays
Tweet
Share
E-mailGet Alerts RVNC Hot Sheet
Price: $3.65 --0%
Rating Summary:
4 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
4 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Barclays analyst Balaji Prasad lowered the price target on Revance Therapeutic (NASDAQ: RVNC) to $3.00 (from $7.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Shiseido Co Ltd. (4911:JP) (SSDOY) PT Lowered to JPY2,750 at Nomura/Instinet
- Goldman Sachs Upgrades Plains All American (PAA) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
